A
Antonio G. Hermosillo
Researcher at National Autonomous University of Mexico
Publications - 66
Citations - 9168
Antonio G. Hermosillo is an academic researcher from National Autonomous University of Mexico. The author has contributed to research in topics: Vasovagal syncope & Heart rate variability. The author has an hindex of 22, co-authored 66 publications receiving 8361 citations.
Papers
More filters
Journal ArticleDOI
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger,John H. Alexander,Renato D. Lopes,Elaine M. Hylek,Michael G. Hanna,Hussein R. Al-Khalidi,Jack Ansell,Dan Atar,Alvaro Avezum,M. Cecilia Bahit,Rafael Diaz,J. Donald Easton,Justin A. Ezekowitz,Greg C. Flaker,David A. Garcia,Margarida Geraldes,Bernard J. Gersh,Sergey P. Golitsyn,Shinya Goto,Antonio G. Hermosillo,Stefan H. Hohnloser,John D. Horowitz,Puneet Mohan,Petr Jansky,Basil S. Lewis,Jose Lopez-Sendon,Prem Pais,Alexander Parkhomenko,Jun Zhu,Lars Wallentin +29 more
TL;DR: In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality.
Journal ArticleDOI
Circadian studies of autonomic nervous balance in patients with fibromyalgia: A heart rate variability analysis
TL;DR: Individuals with fibromyalgia have diminished 24-hour heart rate variability due to an increased nocturnal predominance of the low-frequency band oscillations consistent with an exaggerated sympathetic modulation of the sinus node.
Journal ArticleDOI
Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia.
TL;DR: The main theme of this discussion will be that most (if not all) of these multisystem symptoms of FM could be explained on the basis of autonomic nervous system (ANS) dysfunction.
Journal ArticleDOI
Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)
Greg C. Flaker,Renato D. Lopes,Sana M. Al-Khatib,Antonio G. Hermosillo,Stefan H. Hohnloser,Brian Tinga,Jun Zhu,Puneet Mohan,David A. Garcia,Jozef Bartunek,Dragos Vinereanu,Steen Husted,Veli-Pekka Harjola,Mårten Rosenqvist,John H. Alexander,Christopher B. Granger,Aristotle Committees,Investigators +17 more
TL;DR: In this paper, the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial was used to determine the risk of major clinical and thrombo-embolic events after cardioversion for atrial fibrillation in subjects treated with apixaban compared with warfarin.
Journal Article
Orthostatic sympathetic derangement in subjects with fibromyalgia.
Manuel Martínez-Lavín,Antonio G. Hermosillo,C. Mendoza,R. Ortiz,J. C. Cajigas,Carlos Pineda,Nava A,Manuel C. Vallejo +7 more
TL;DR: In FM, there is a deranged sympathetic response to orthostatic stress, which may have implications regarding the pathogenesis of FM.